跳至主要内容
临床试验/NCT00464204
NCT00464204已完成3 期

Effects of Voluven on Hemodynamics and Tolerability of Enteral Nutrition in Patients With Severe Sepsis

Fresenius Kabi24 个研究点 分布在 2 个国家目标入组 196 人开始时间: 2007年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
196
试验地点
24
主要终点
Amount of Study Drug Required to Achieve Initial Hemodynamic Stabilization

研究概览

简要总结

The rapidity and the quality of fluid resuscitation in patients with severe sepsis are important factors for the prevention of secondary multi-organ failure. Vascular filling may also have an impact on tolerability of enteral nutrition. The earliness and quantity of calories provided by enteral nutrition may have an impact on morbidity and mortality. This study will asses the effects of volume expansion on hemodynamics and tolerability of enteral nutrition in patients with severe sepsis. A Data Monitoring Committee will review regularly safety data of the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Severe sepsis
  • Requirement for fluid resuscitation

排除标准

  • serum creatinine > 300µmol/L
  • Chronic renal failure
  • Anuria lasting more than 4 hours
  • Requirement for renal support

研究组 & 干预措施

Voluven® Arm

Experimental

干预措施: 6 % Hydroxyethylstarch 130/0.4 = "Voluven®" (Drug)

0.9 % NaCl

Active Comparator

干预措施: 0.9 % NaCl (Drug)

结局指标

主要结局

Amount of Study Drug Required to Achieve Initial Hemodynamic Stabilization

时间窗: until hemodynamic stabilization (up to 48 hours)

Initial hemodynamic stabilization (HDS) was defined as normalization of mean arterial pressure (MAP) and at least two of the three parameters central venous pressure (CVP), urine output and central venous oxygen saturation and maintaining this normalization over a period of four hours, with no increase in the infusion of vasopressors, or ionotropic therapy and with no more than 1 L of additional study drug administration within these four hours.

次要结局

  • Time From Start of Fluid Resuscitation With Study Drug to the Initial Hemodynamic Stabilization(until hemodynamic stabilization (up to 48 hours))
  • Quantity of Study Drug in 4 Days(4 days)
  • Time From Start of Study Drug to Start of Enteral Nutrition in the Subgroup of Patients Who Received Enteral Nutrition(Until start of enteral nutrition (up to 48 hours))
  • Time From Start of Fluid Resuscitation With Study Drug to Start of Enteral Nutrition After Hemodynamic Stabilization(up to 48 hours)
  • Total Amount of Enteral Calories During the First Seven Days of Enteral Nutrition(7 days)
  • Length of Stay in the Intensive Care Unit (ICU)(Until discharge from ICU (up to day 90))
  • Length of Stay in the ICU(Until discharge from ICU (up to Day 90))
  • Length of Stay in the Hospital(Until discharge from hospital (up to day 90))
  • Area Under the Curve (AUC) of Sepsis-related Organ Failure Assessment (SOFA) Score Per Day From Screening to Day 4(From Screening to Day 4)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (24)

Loading locations...

相似试验